Results 141 to 150 of about 14,298 (222)

Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies. [PDF]

Elife
Lin Y, Liou B, Fannin V, Adler S, Mayhew CN, Hammonds JE, Hu YC, Tchieu J, Zhang W, Zhao X, Beres RL, Setchell KDR, Kaynak A, Qi X, Feldman RA, Sun Y.   +15 more
europepmc   +1 more source

Bioengineered cell therapies for pediatric solid tumors: unmet needs and a measurement-integrated approach. [PDF]

Prog Biomed Eng (Bristol)
Sandoval-Castellanos AM, Ahn YR, Canter RJ, Brown EG, Kim J.   +4 more
europepmc   +1 more source

Case Report: Early introduction of anti-GD2 immunotherapy during induction chemotherapy in high-risk neuroblastoma: two pediatric cases. [PDF]

Front Oncol
Hu T, Li J, He L, Zhang X, Xu J, Li T, Zhou L.   +6 more
europepmc   +1 more source

Changes in the Metabolism of GD2-Specific Murine CAR-T Cells After Co-Culturing with Melanoma. [PDF]

Int J Mol Sci
Bulygin A, Philippova J, Basov N, Butikova E, Sotnikova M, Sotnikova Y, Patrushev Y, Rogachev A, Gaisler E, Pokrovsky A, Shiku H, Sennikov S.   +11 more
europepmc   +1 more source

SIRPα ablated iPSC-derived macrophages resist hypophagia and enhance mAb-dependent and CAR-mediated cytotoxicity of solid tumors. [PDF]

Mol Ther Oncol
Smith PR, Kabir ME, Zhang J, Maufort JP, Forsberg MH, Sedzro DM, Berres M, Thomson JA, Capitini CM, Slukvin II.   +9 more
europepmc   +1 more source

Sol-Gel-Synthesized Mn⁴⁺-Doped Sr₉Gd₂W₄O₂₄ Red Phosphor: Structural, Optical, and EPR Studies for Deep-Red LEDs and Plant Growth Lighting Applications. [PDF]

Luminescence
Singh V, Kaur S, Devi CBA, Nande A, Boddula R, Rao AS, Joo JB.   +6 more
europepmc   +1 more source

DFT Calculations of Structure and IR Spectra of Gd₂@C₈₂ Endofullerenes. [PDF]

Molecules
Nechaev IV, Krisilov AV, Chernov VE, Holyavka MG.   +3 more
europepmc   +1 more source

Chimeric Antigen Receptor-T Cell Therapy for Pediatric and Young Adult Primary Central Nervous System Tumors: A Systematic Review of Early Phase Clinical Trials with a Focus on Diffuse Midline Glioma. [PDF]

Target Oncol
Sanikommu S, Santos AN, Dawoud B, Shah KH, Vazquez S, Shah AH, Lu VM.   +6 more
europepmc   +1 more source

Novel CAR T cell blend targeting PDPN and GD2 to overcome glioblastoma heterogeneity. [PDF]

J Immunother Cancer
Hübner J, Alsalkini M, McFleder R, Toppeta F, Wagner J, Liguori R, Grams B, Meyer-Hofmann M, Diener L, Monoranu CM, Hagemann C, Ferrazzi F, Ip CW, Ernestus RI, Einsele H, Hudecek M, Löhr M, Nerreter T, Nickl V.   +18 more
europepmc   +1 more source

GD2 Identifies Cancer Stemness in Glioblastoma and Phytoalexin Library Screen Identifies Potential Novel Natural Inhibitors. [PDF]

Int J Mol Sci
Nguyen K, McConnell E, Tran M, Burow N, Edwards O, Cheng T, Cavanaugh JE, Flaherty PT, Izadpanah R, Collins-Burow BM, Boue S, Burow ME.   +11 more
europepmc   +1 more source